Formulated for androgenetic alopecia to manage follicle health and support hair regrowth.
Mechanism of Action
Topical minoxidil promotes hair growth by prolonging the anagen phase and increasing hair follicle size. It likely works through vasodilation and stimulation of vascular endothelial growth factor (VEGF).
Route of Administration
Topical
Onset Time
2–4 months
Duration
Ongoing use required
Contraindications
Hypersensitivity to minoxidil, Inflamed or infected scalp
Severe Adverse Events
Chest pain, Tachycardia, Severe allergic reaction — requires immediate medical attention
Common Side Effects
Scalp irritation, Dry skin, Pruritus
Uncommon Side Effects
Hypertrichosis, Headache, Rash
Drug Interactions
Alcohol, Guanethidine, Tretinoin, Anthralin
Pregnancy Safety Warnings
FDA Category C: Use with caution. Breastfeeding: Excreted in milk; compatible with caution.
Age Restrictions
Not recommended for use in patients under 18 years of age.
Information related to Rogaine is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
